25300 Federal Register / Vol. 87, No. 82 / Thursday, April 28, 2022 / Notices 

comments be submitted electronically 

through the Federal eRulemaking Portal, 

which provides the ability to type short 

comments directly into the comment 

field on the web page or attach a file for 

lengthier comments. Please go to 

https://www.regulations.gov and follow 

the online instructions at that site for 

submitting comments. Upon submission 

of your comment, you will receive a 

Comment Tracking Number. Please be 

aware that submitted comments are not 

instantaneously available for public 

view on https://www.regulations.gov. If 

you have received a Comment Tracking 

Number, your comment has been 

successfully submitted and there is no 

need to resubmit the same comment.’’ 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.33(a), this 

is notice that on January 26, 2022, 

SpecGx LLC, 3600 North Second Street, 

Saint Louis, Missouri 63147–3457, 

applied to be registered as a bulk 

manufacturer of the following basic 

class(es) of controlled substance(s): 

Controlled substance Drug code Schedule 

Gamma Hydroxybutyric Acid ................................................................................................................................................. 2010 I 

Tetrahydrocannabinols .......................................................................................................................................................... 7370 I 

Codeine-N-oxide .................................................................................................................................................................... 9053 I 

Noroxymorphone ................................................................................................................................................................... 9145 I 

Difenoxin ................................................................................................................................................................................ 9168 I 

Morphine-N-oxide .................................................................................................................................................................. 9307 I 

Normorphine .......................................................................................................................................................................... 9313 I 

Alphamethadol ....................................................................................................................................................................... 9605 I 

Betamethadol ......................................................................................................................................................................... 9609 I 

Norlevorphanol ...................................................................................................................................................................... 9634 I 

Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) ..................................................................................... 9821 I 

Butyryl Fentanyl ..................................................................................................................................................................... 9822 I 

Fentanyl related-compounds as defined in 21 CFR 1308.11(h) ........................................................................................... 9850 I 

Amphetamine ......................................................................................................................................................................... 1100 II 

Methamphetamine ................................................................................................................................................................. 1105 II 

Lisdexamfetamine .................................................................................................................................................................. 1205 II 

Methylphenidate .................................................................................................................................................................... 1724 II 

Nabilone ................................................................................................................................................................................. 7379 II 

ANPP (4-Anilino-N-phenethyl-4-piperidine) ........................................................................................................................... 8333 II 

Phenylacetone ....................................................................................................................................................................... 8501 II 

Codeine ................................................................................................................................................................................. 9050 II 

Dihydrocodeine ...................................................................................................................................................................... 9120 II 

Oxycodone ............................................................................................................................................................................. 9143 II 

Hydromorphone ..................................................................................................................................................................... 9150 II 

Diphenoxylate ........................................................................................................................................................................ 9170 II 

Ecgonine ................................................................................................................................................................................ 9180 II 

Hydrocodone ......................................................................................................................................................................... 9193 II 

Levorphanol ........................................................................................................................................................................... 9220 II 

Meperidine ............................................................................................................................................................................. 9230 II 

Meperidine intermediate-A .................................................................................................................................................... 9232 II 

Meperidine intermediate-B .................................................................................................................................................... 9233 II 

Meperidine intermediate-C .................................................................................................................................................... 9234 II 

Methadone ............................................................................................................................................................................. 9250 II 

Methadone intermediate ........................................................................................................................................................ 9254 II 

Dextropropoxyphene, bulk (non-dosage forms) .................................................................................................................... 9273 II 

Morphine ................................................................................................................................................................................ 9300 II 

Oripavine ............................................................................................................................................................................... 9330 II 

Thebaine ................................................................................................................................................................................ 9333 II 

Opium tincture ....................................................................................................................................................................... 9630 II 

Opium, powdered .................................................................................................................................................................. 9639 II 

Oxymorphone ........................................................................................................................................................................ 9652 II 

Noroxymorphone ................................................................................................................................................................... 9668 II 

Alfentanil ................................................................................................................................................................................ 9737 II 

Remifentanil ........................................................................................................................................................................... 9739 II 

Sufentanil ............................................................................................................................................................................... 9740 II 

Tapentadol ............................................................................................................................................................................. 9780 II 

Fentanyl ................................................................................................................................................................................. 9801 II 

The company plans to bulk 

manufacture the listed controlled 

substances for the internal use 

intermediates or for sale to its 

customers. In reference to dug code 

7370 (Tetrahydrocannabinols), the 

company plans to bulk manufacture this 

drug as synthetic. No other activities for 

these drug codes are authorized for this 

registration. 

Matthew J. Strait, 

Deputy Assistant Administrator. 

[FR Doc. 2022–09035 Filed 4–27–22; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–999] 

Importer of Controlled Substances 

Application: Royal Emerald 

Pharmaceuticals Research and 

Development 

AGENCY: Drug Enforcement 

Administration, Justice. 


jspears on DSK121TN23PROD with NOTICES1
Federal Register / Vol. 87, No. 82 / Thursday, April 28, 2022 / Notices 25301 

ACTION: Notice of application. 

SUMMARY: Royal Emerald 

Pharmaceuticals has applied to be 

registered as an importer of basic 

class(es) of controlled substance(s). 

Refer to Supplemental Information 

listed below for further drug 

information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may submit 

electronic comments on or objections to 

the issuance of the proposed registration 

on or before May 31, 2022. Such persons 

may also file a written request for a 

hearing on the application on or before 

May 31, 2022. 

ADDRESSES: The Drug Enforcement 

Administration requires that all 

comments be submitted electronically 

through the Federal eRulemaking Portal, 

which provides the ability to type short 

comments directly into the comment 

field on the web page or attach a file for 

lengthier comments. Please go to 

https://www.regulations.gov and follow 

the online instructions at that site for 

submitting comments. Upon submission 

of your comment, you will receive a 

Comment Tracking Number. Please be 

aware that submitted comments are not 

instantaneously available for public 

view on https://www.regulations.gov. If 

you have received a Comment Tracking 

Number, your comment has been 

successfully submitted and there is no 

need to resubmit the same comment. All 

requests for a hearing must be sent to: 

(1) Drug Enforcement Administration, 

Attn: Hearing Clerk/OALJ, 8701 

Morrissette Drive, Springfield, Virginia 

22152; and (2) Drug Enforcement 

Administration, Attn: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for a hearing should 

also be sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.34(a), this 

is notice that on March 25, 2022, Royal 

Pharmaceuticals Research and 

Development, 14011 Palm Drive, Desert 

Hot Springs, California 92240, applied 

to be registered as an importer of the 

following basic class(es) of controlled 

substance(s): 

Marihuana Extract .. 7350 I 

Marihuana ............... 7360 I 

Tetrahydrocannabinols.7370 I 

The company plans to import 

Marihuana seeds and immature 

Marihuana plants in the form of Active 

Pharmaceutical Ingredients (API) and 

botanical raw materials for DEAapproved legitimate scientific medical 

research and/or industrial purposes. 

Approval of permit applications will 

occur only when the registrant’s 

business activity is consistent with what 

is authorized under 21 U.S.C. 952(a)(2). 

Authorization will not extend to the 

import of Food and Drug 

Administration-approved or nonapproved finished dosage forms for 

commercial sale. 

Matthew J. Strait, 

Deputy Assistant Administrator. 

[FR Doc. 2022–09061 Filed 4–27–22; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–996] 

Importer of Controlled Substances 

Application: VHG Labs DBA LGC 

Standards 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: VHG Labs DBA LGC 

Standards has applied to be registered 

as an importer of basic class(es) of 

controlled substance(s). Refer to 

Supplemental Information listed below 

for further drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may submit 

electronic comments on or objections to 

the issuance of the proposed registration 

on or before May 31, 2022. Such persons 

may also file a written request for a 

hearing on the application on or before 

May 31, 2022. 

ADDRESSES: The Drug Enforcement 

Administration requires that all 

comments be submitted electronically 

through the Federal eRulemaking Portal, 

which provides the ability to type short 

comments directly into the comment 

field on the web page or attach a file for 

lengthier comments. Please go to 

https://www.regulations.gov and follow 

the online instructions at that site for 

submitting comments. Upon submission 

of your comment, you will receive a 

Comment Tracking Number. Please be 

aware that submitted comments are not 

instantaneously available for public 

view on https://www.regulations.gov. If 

you have received a Comment Tracking 

Number, your comment has been 

successfully submitted and there is no 

need to resubmit the same comment. All 

requests for a hearing must be sent to: 

(1) Drug Enforcement Administration, 

Attn: Hearing Clerk/OALJ, 8701 

Morrissette Drive, Springfield, Virginia 

22152; and (2) Drug Enforcement 

Administration, Attn: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for a hearing should 

also be sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.34(a), this 

is notice that on February 18, 2022, 

VHG Labs DBA LGC Standards, 3 

Perimeter Road, Manchester, New 

Hampshire 03103, applied to be 

registered as an importer of the 

following basic class(es) of controlled 

substance(s): 

Controlled substance Drug code Schedule 

Cathinone .............................................................................................................................................................................. 1235 I 

Methcathinone ....................................................................................................................................................................... 1237 I 

Naphyrone ............................................................................................................................................................................. 1258 I 

N-Ethylamphetamine ............................................................................................................................................................. 1475 I 

JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole) ......................................................................................................... 6250 I 

SR-18 (Also known as RCS-8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl) indole) ....................................................... 7008 I 

APINACA and AKB48 N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide .................................................................... 7048 I 

JWH-081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) indole) ......................................................................................................... 7081 I 

SR-19 (Also known as RCS-4) (1-Pentyl-3-[(4-methoxy)-benzoyl] indole ............................................................................ 7104 I 

JWH-018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) .................................................................................... 7118 I 

JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl) indole) ............................................................................................................ 7122 I 

UR-144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone ........................................................................ 7144 I 

JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl) indole) ............................................................................................................ 7203 I 

Ibogaine ................................................................................................................................................................................. 7260 I 


jspears on DSK121TN23PROD with NOTICES1